Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
601607.SS
STRONG BUYGet insider-trade alertsShanghai Pharmaceuticals Holding Co., Ltd · Healthcare · China · $8.4B · Avg Vol: $26M/d
COMPANY DESCRIPTION
Shanghai Pharmaceuticals Holding Co., Ltd. is a vertically integrated healthcare giant engaged in pharmaceutical research, manufacturing, distribution, and retail. The company holds a dominant market position as China's second-largest pharmaceutical distributor, with an absolute stronghold in the affluent East China region. It serves as a critical gateway partner for multinational pharmaceutical companies seeking distribution and commercialization in China.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34.2B | 38.3B | 40.5B | 41.8B | 6.9% | 42.4B | 43.9B | 46.7B | 5.8% |
| EPS | 0.24 | 0.15 | 0.18 | 0.23 | -1.5% | 0.23 | — | — | — |
| Shares | 3.7B | 3.7B | 3.7B | 3.7B | +0.3% | 2.8B | — | — | — |
| Debt | 5.7B | 6.8B | 7.2B | 7.7B | 10.7% | 8.7B | — | — | — |
| Equity | 9.9B | 10.1B | 10.6B | 11.2B | 4.2% | — | — | — | — |
| Op CF | 698.6M | 770.5M | 858.2M | 906.4M | 9.1% | 1.1B | — | — | — |
| Inv CF | -1.8B | -367.0M | 61.3M | -586.5M | — | — | — | — | — |
| Fin CF | 1.8B | 34.1M | -274.5M | -832.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 601607.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 601607.SS | Shanghai Pharmaceuticals Holding Co., Ltd(you) | $8.4B | 91 | STRONG BUY |
| 1099.HK | Sinopharm Group Co. Ltd. | $6.3B | 96 | STRONG BUY |
| 0874.HK | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $2.9B | 85 | STRONG BUY |
| 600511.SS | China National Medicines Corporation Ltd. | $2.9B | 98 | STRONG BUY |
| 600998.SS | Jointown Pharmaceutical Group Co., Ltd | $3.4B | 80 | BUY |
| 000028.SZ | China National Accord Medicines Corporation Ltd. | $1.7B | 96 | STRONG BUY |
| 301015.SZ | Qingdao Baheal Medical INC. | $1.5B | 86 | STRONG BUY |
| 600056.SS | China Meheco Group Co., Ltd. | $1.9B | 80 | BUY |
| 603368.SS | Guangxi LiuYao Group Co., Ltd | $854M | 92 | STRONG BUY |
| 600739.SS | Liaoning Cheng Da Co., Ltd. | $2.2B | 56 | HOLD |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%